Medical and Surgical Management of Symptomatic Carotid Stenosis

Carotid bifurcation stenosis is an important cause of ischaemic stroke, particularly in patients with recent transient ischaemic attack or minor stroke. Large randomized trials of endarterectomy have shown that surgery reduces the risk of stroke in patients with ≥ 50% recently symptomatic carotid stenosis, and more recent research has gone some way to wards identifying which patients benefit the most. Individual risk modelling has been shown to be useful in selecting patients with the most to gain from endarterectomy for symptomatic stenosis, although timely surgery and optimal medical treatment are of equal importance.

[1]  G. Moneta,et al.  Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular Events: A Prospective Assessment With MRI—Initial Results , 2007 .

[2]  H. Markus Can microemboli on transcranial Doppler identify patients at increased stroke risk? , 2006, Nature Clinical Practice Cardiovascular Medicine.

[3]  S Claiborne Johnston,et al.  Recent advances in management of transient ischaemic attacks and minor ischaemic strokes , 2006, The Lancet Neurology.

[4]  G. Moneta Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions Heart , 2022 .

[5]  Martin J Graves,et al.  Identification of Culprit Lesions After Transient Ischemic Attack by Combined 18F Fluorodeoxyglucose Positron-Emission Tomography and High-Resolution Magnetic Resonance Imaging , 2005, Stroke.

[6]  P. Rothwell,et al.  Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke , 2005, Neurology.

[7]  P. Rothwell,et al.  A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack , 2005, The Lancet.

[8]  G. Fraedrich,et al.  Carotid endarterectomy after ischemic stroke--is there a justification for delayed surgery? , 2005, European Journal of Vascular and Endovascular Surgery.

[9]  P. Rothwell,et al.  A Systematic Review of the Associations between Age and Sex and the Operative Risks of Carotid Endarterectomy , 2005, Cerebrovascular Diseases.

[10]  P. Rothwell,et al.  The Need for Urgency in Identification and Treatment of Symptomatic Carotid Stenosis Is Already Established , 2005, Cerebrovascular Diseases.

[11]  E. Ringelstein,et al.  Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial , 2005, Circulation.

[12]  H. Markus,et al.  Asymptomatic Embolization Detected by Doppler Ultrasound Predicts Stroke Risk in Symptomatic Carotid Artery Stenosis , 2005, Stroke.

[13]  T. Hölzenbein,et al.  Protected carotid-artery stenting versus endarterectomy in high-risk patients , 2005, European Surgery.

[14]  S. Kasner,et al.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.

[15]  S. Gutnikov,et al.  From subgroups to individuals: general principles and the example of carotid endarterectomy , 2005, The Lancet.

[16]  H. Diener,et al.  Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events: A Meta-Analysis of Individual Patient Data From Randomized Controlled Trials , 2005, Stroke.

[17]  S. Gutnikov,et al.  Sex Difference in the Effect of Time From Symptoms to Surgery on Benefit From Carotid Endarterectomy for Transient Ischemic Attack and Nondisabling Stroke , 2004, Stroke.

[18]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trial , 2004 .

[19]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[20]  W. Hacke,et al.  The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trial , 2004, Cerebrovascular Diseases.

[21]  J. Tu,et al.  The high risk of stroke immediately after transient ischemic attack , 2004, Neurology.

[22]  M. Eliasziw,et al.  Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.

[23]  R. Collins,et al.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.

[24]  P. Rothwell,et al.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies , 2004, Neurology.

[25]  P. Rothwell,et al.  Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease , 2003, Stroke.

[26]  M. Hennerici,et al.  Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.

[27]  P. Rothwell,et al.  Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. , 2003, Stroke.

[28]  A. Buchan,et al.  The fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) trial , 2003 .

[29]  S. A. Gutnikov,et al.  Reanalysis of the Final Results of the European Carotid Surgery Trial , 2003, Stroke.

[30]  S. Gutnikov,et al.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.

[31]  S. Engelter,et al.  Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. , 2003, The Cochrane database of systematic reviews.

[32]  M. Forsting Carotid Angioplasty and Stenting With and Without Cerebral Protection , 2003 .

[33]  R. Collins,et al.  MRC/BHF Heart Protection Study , 2002, The Lancet.

[34]  M. Ezekowitz,et al.  Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy , 2002, Circulation.

[35]  H. Tilanus Treatment of oesophageal rupture , 2002, The Lancet.

[36]  A. Hingorani,et al.  Pseudo-occlusions of the internal carotid artery: a rationale for treatment on the basis of a modified carotid duplex scan protocol. , 2002, Journal of vascular surgery.

[37]  R. McClure,et al.  Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. , 2001, Journal of the American College of Cardiology.

[38]  C. Di Mario,et al.  Cerebral Protection With Filter Devices During Carotid Artery Stenting , 2001, Circulation.

[39]  J M Bland,et al.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.

[40]  H. Markus,et al.  Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. , 2001, Brain : a journal of neurology.

[41]  M. Alberts,et al.  Results of a Multicenter Prospective Randomized Trial of Carotid Artery Stenting vs. Carotid Endarterectomy , 2001, Stroke.

[42]  A comparison of CT versus MR imaging in acute stroke using ASPECTS: Will the “new” replace the “old” as the preferred imaging modality? , 2001 .

[43]  S. Sidney,et al.  Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.

[44]  C Caltagirone,et al.  Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. , 2000, JAMA.

[45]  P. Rothwell,et al.  Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists' Collaborative Group. , 2000, Stroke.

[46]  C. Warlow,et al.  Local versus general anaesthesia for carotid endarterectomy. , 1996, The Cochrane database of systematic reviews.

[47]  C. Warlow,et al.  Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study , 1999, The Lancet.

[48]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[49]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[50]  Zheng-Ming Chen,et al.  CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.

[51]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[52]  R. Matz Carotid and Vertebral Artery Transluminal Angioplasty Study , 1997 .

[53]  W. Mali,et al.  Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery. A 1H-MR spectroscopic imaging study. , 1995, Stroke.

[54]  A. Chant,et al.  Can overall results of clinical trials be applied to all patients? , 1995, Lancet.

[55]  J. Rösch,et al.  Nonoperative treatment of arterial occlusive disease: a radiologically facilitated technique. , 1967, Radiologic clinics of North America.